Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find out whether stress doses of hydrocortisone attenuate coagulation dysfunction in patients with septic shock. And discuss the probable mechanism by which little doses of hydrocortisone influence coagulation system in sepsis.


Clinical Trial Description

Patients were randomized to receive either low-dose hydrocortisone or matching placebo.Severity of coagulopathy was estimated using ISTH DIC score. We determined the complications and mortality in two groups, and analyzed the relationship between hydrocortisone and coagulopathy. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Coagulation Dysfunction in Septic Shock
  • Hemodynamic Improvement Induced by Hydrocortisone
  • Shock
  • Shock, Septic

NCT number NCT02114710
Study type Interventional
Source Nanjing PLA General Hospital
Contact
Status Completed
Phase Phase 3
Start date May 2009
Completion date October 2012